• Aucun résultat trouvé

Classifying Adverse Events from Clinical Trials

N/A
N/A
Protected

Academic year: 2022

Partager "Classifying Adverse Events from Clinical Trials"

Copied!
3
0
0

Texte intégral

(1)

!"#$$%&'%()*+,-./$.*0-.(1$*&/23*!"%(%4#"*5/%#"$*

!"#$%#&'(%)%**"+',-./%#&'!#%&0/%1'

2$-3"#0-45'67'24%/+'!-68"&-.%*'9$76#8%4-.0+')%*4'(%:"';-45+'2<+'2)='

+6$1/#417*</"'>0"'67'%&3"#0"'"3"$4'&%4%'7#68'-$3"04-?%46#@-$-4-%4"&'.*-$-.%*'4#-%*0+'6>40-&"'67' 4/"' 04>&5' "3"$4' -40"*7+' /%0' $64' A""$' B#%.4-.%*' A".%>0"' 67' 4/"' %A0"$."' 67' >$-76#8' &%4%' .6**".4-6$C'</"'#"*"%0"'67';<;=D'ECF'B#63-&"&'%'.6$4#6**"&'36.%A>*%#5'76#'0"3"#%*'.68B6$"$40' 67'%&3"#0"'"3"$4'&%4%+'A>4'1%0'&-77-.>*4'46'>0"'-$'%'#"0"%#./'0"44-$?C'G"'/%3"'.#"%4"&'%'1"A@

A%0"&' %BB*-.%4-6$' 4/%4' .68A-$"0' &%4%' 7#68' .*-$-.%*' 4#-%*0' %$&' 4/"' ;<;=D' .*%00-7-.%4-6$' -$76#8%4-6$'-$46'%'H>"#5%A*"'&%4%A%0"C'

'

8* 9(1/2,:41%2(*

</"' B/%#8%.">4-.%*' %$&' &"3-."' #"0"%#./' .688>$-45' /%0' A""$' %.4-3"*5' -$36*3"&' -$' .6**".4-$?+' .*%00-75-$?' %$&' #"B6#4-$?' %&3"#0"'

"3"$40' I=D0J' 0-$."' 4/"' %&3"$4' 67' "776#40' 46' -8B#63"'/>8%$'0>AK".4'B#64".4-6$'LM+NOC'G-4/-$' 4/-0' &68%-$' 4/"#"' /%0' A""$' %.."B4%$."' 67' 4"#8-$6*6?5' 04%$&%#&0' 76#' =D0C' P61"3"#+' -$3"04-?%46#' -$-4-%4"&' .*-$-.%*' #"0"%#./' 8%:"0'

>B' 4/"' 8%K6#-45' 67' .*-$-.%*' #"0"%#./' .6$&>.4"&' 1-4/-$' 4/"' 2$-4"&' )4%4"0' LEO'%$&' 1-4/-$' 4/-0'

&68%-$' >0"' 67' 04%$&%#&' 4"#8-$6*6?5' %$&' .*%00-7-.%4-6$'-0'$64'%'.6886$'B#%.4-."C'

9$-4-%*' %$&' 76**61@>B' #"B6#4-$?' 67' =D0'

&>#-$?'.*-$-.%*'4#-%*0'-0'B#-8%#-*5'&#-3"$'A5'4/"'

#"?>*%46#5'B#6."00+'1/-./'-0'&"4"#8-$"&'A5'4/"'

#"H>-#"8"$40' 67' 4/"' 0B6$06#+' 4/"' Q66&' %$&' R#>?' =&8-$-04#%4-6$' IQR=J' LSO' %$&' 4/"' T77-."' 67'P>8%$',"0"%#./'U#64".4-6$'ITP,UJ'LVOC'</"'

&%4%'.6**".4"&'%#"'>0"&'46'&"4"#8-$"'-7'4/"'=D' -0' 0"#-6>0+' -7' 4/"' =D' %77".40' 4/"' "$#6**8"$4' 04%4>0' 67' 4/"' 04>&5' B%#4-.-B%$4+' %$&' 1/"4/"#' 4/"' =D' -0' #"*%4"&' 46' 4/"' 04>&5' &#>?+' &"3-."' 6#' B#6."&>#"C' T$."' 4/-0' B#6."00' -0' .68B*"4"+' 76#8%*' .*%00-7-.%4-6$' 67' 4/"' %&3"#0"' "3"$4' -0'

#"H>-#"&' 76#' #"B6#40' 46' &%4%' %$&' 0%7"45' 86$-46#-$?' .688-44""0' %$&' %0' B%#4' 67' 4/"' 04%4-04-.%*'%$%*50-0'B*%$C''

G"' /%3"' .#"%4"&' %' 04#%-?/476#1%#&+' A#610"#@A%0"&' %BB*-.%4-6$' 46' B#63-&"' &68%-$'

"WB"#40' "$6>?/' -$76#8%4-6$' 46' .*%00-75' =D0'

>0-$?' 4/"' X%4-6$%*' ;%$."#' 9$04-4>4"' ;6886$'

<"#8-$6*6?5' ;#-4"#-%' 76#' =&3"#0"' D3"$40' I;<;=DJ' LYO+' 1/-./' -0' %$' -$-4-%*' 04"B' -$' 4/"' B#6."00' 67' &"0-?$-$?' %$' 6$46*6?5' 76#' .*-$-.%*'

#"0"%#./'=D0C' '

;* <#4=)/2:(,*

9$3"04-?%46#@-$-4-%4"&' .*-$-.%*' #"0"%#./' -$' 4/"' 2$-4"&' )4%4"0' 4/%4' -$36*3"0' />8%$' B%#4-.-@

B%$40' #6>4-$"*5' -$.*>&"0' B#6."00"0' 76#' -&"$4-75-$?'=D0'%$&'.6**".4-$?'&%4%'%A6>4'4/"'

"3"$4C' Q#"H>"$4*5' 4/"' B"#06$I0J' .6**".4-$?' 4/"0"' &%4%' %#"' .*-$-.%*' .66#&-$%46#0' 6#' 04>&5'

$>#0"0' %$&' $64' 4/"' B#-$.-B%*' -$3"04-?%46#C' G/"$' =D0' %#"' .6$0-&"#"&' 46' A"' 0"#-6>0+' %' 8%$&%46#5'#"B6#4-$?'B#6."00'-0'>0>%**5'04%#4"&C'

</-0'B#6."00'$64-7-"0'3%#-6>0'#"?>*%46#5'"$4-4-"0' I9,!+' R)Z!+' 0B6$06#+' QR=J' L[@\O' 1-4/' %' 8-$-8>8' &%4%' 0"4'67'-$76#8%4-6$' 4/%4' 7>*7-**0' 4/"'0/6#4@4"#8'#"H>-#"8"$40'76#'#"B6#4-$?+'A>4'

&6"0' $64' B#63-&"' "$6>?/' 8"4%&%4%' %A6>4' 4/"'

"3"$4' 46' A"' >0"7>*' 6>40-&"' 4/"' .6$4"W4' 67' 4/"' -$-4-%*' #"B6#4C' =D0' 4/%4' %#"' &"4"#8-$"&' 46' A"'

$6$@0"#-6>0' 8%5' $64' #"."-3"' %$5' 7>#4/"#'

"3%*>%4-6$'64/"#'4/%$'4/"-#'7#"H>"$.5C'

;*%00-75-$?' =D0' -$' %' 04%$&%#&-]"&' 1%5' I0504"8'6#?%$'.*%00+'4"#8+'&"7-$-4-6$+'?#%&"'%$&' 0"3"#-45J' #"H>-#"0' 068"6$"' 1-4/' &68%-$' :$61*"&?"' 67' 4/"' .*-$-.%*' B#"0"$4%4-6$+' 4/"' 04>&5' B#646.6*' %$&' 4/"' .*%00-7-.%4-6$' 04%$&%#&C'

;6##"*%4-$?'%$&'"3%*>%4-$?'%**'67'4/"0"'&%4%'-0' 4-8"'.6$0>8-$?+'#"H>-#-$?'0-8>*4%$"6>0'#"3-"1' 67'8>*4-B*"'&%4%'06>#."0C'

>* ?6@.41%-.*

T>#' 6AK".4-3"' 1%0' 46' .#"%4"' %' 1"A@A%0"&'

%BB*-.%4-6$' 4/%4' .6>*&' -8B6#4' =D' &%4%' 7#68' %' .*-$-.%*' 6#' &"3-."' 04>&5' %$&' &-0B*%5' 4/%4' &%4%+'

#"*%4"&' 04>&5' &%4%' %$&' %' 0"%#./' 1-$&61' 67'

;<;=D' &%4%' 1-4/-$' %' 0-$?*"' A#610"#' B%?"C'

</-0'&-0B*%5'%**610'%'&68%-$'"WB"#4'46'H>-.:*5'

"3%*>%4"' 4/"' =D' &%4%+' &"4"#8-$"' 4/"' .6##".4' ,&%2,QWHUQDWLRQDO&RQIHUHQFHRQ%LRPHGLFDO2QWRORJ\ā%XIIDOR1<86$

5HSUHVHQWLQJ$GYHUVH(YHQWV:RUNVKRS-XO\

(2)

!"!#$% &'())*+*&(,*-.% (./% ,01.2% 3*,0% (% +13%

4-5)1%&'*&6)2%'*.6%,01)1%/(,(%(./%),-71%,014%*.%

(% .13% #$% &'())*+*&(,*-.% ,(8'1% 30*&0% *)%

())-&*(,1/%3*,0%,01%),5/9%41,(%/(,(:%

!" #$%&'()"

;*.&1% ,01% (<<'*&(,*-.% *)% /(,(8()1% /7*=1.2% 31%

.11/1/% (% /(,(% 4-/1'% ,0(,% &-5'/% *4<-7,%

71)1(7&0% /(,(% 3*,0% (% 4*.*454% -+% 1>,7(&,*-.?

,7(.)<-)1?'-(/% @$"AB% 1++-7,:% C.'9% 41,(% /(,(%

(8-5,% ,01% ),5/9% (./% (% )58)1,% -+% ,01% #$% /(,(%

(71%*4<-7,1/%*.,-%,3-%,(8'1)%@D*E571%FB:%%"0*)%*)%

&5771.,'9% (% 4(.5('% <7-&1))% 5)*.E% (% +-74(,,1/%

,1>,% 1><-7,% +*'1% -7% (% /*71&,% ;GA% H5179% -+% ,01%

),5/9%/(,(8()1:%

"01%<58'*)01/%I!J%!"!#$%/(,(%(71%'-(/1/%

*.,-% 45',*<'1% ,(8'1)% 89% (% )*4*'(7% <7-&1))K%

0-31=172% )*.&1% ,0*)% *)% (% 6.-3.% ),75&,5712% ,01%

<7-&1))% *)% ),7(*E0,+-73(7/% (./% 71H5*71/% -.'9%

301.% !"!#$% /(,(% (71% 5</(,1/:% "01% !"!#$%

/(,(%(71%'-(/1/%*.,-%,0711%,(8'1)%*.%(%71'(,*-.('%

/(,(8()12% L-),E71;GA% MFNO2% ,-% 1.(8'1% +(),17%

)1(7&0*.E% 89% ,01% <17)-.% 1=('5(,*.E% ,01% #$)%

@D*E571%PB:%

"01% (<<'*&(,*-.% *.,17+(&1% (''-3)% ,01% 5)17%

,-%)1'1&,%(%),5/9%,0(,%+*',17)%,01%/*)<'(9%-+%#$%

/(,(:% #)% 1(&0% #$% *)% /*)<'(91/2% ,01% 5)17% &(.%

)1'1&,% (% ;9),14% C7E(.% !'())% @;C!B2% +*',17*.E%

,01% .54817% -+% #$% ,174)% /*)<'(91/2% -7% (.% #$%

,174% /*71&,'9:% C.&1% ,01% L71+1771/% "174% 0()%

811.% )1'1&,1/2% ,01% &-771)<-./*.E% Q7(/1)% (71%

/*)<'(91/:% C.&1% ,01% Q7(/1% 0()% 811.% &0-)1.2%

(''% -+% ,01% /(,(% +7-4% 8-,0% /(,(% )-57&1)% (71%

71(/9% ,-% 81% *.)17,1/% *.,-% ,01% $=('5(,1/% #$%

,(8'1%@D*E571%RB:%

*" +$),-%)"

"01% (<<'*&(,*-.% (''-3)% 5)17)% ,-% =*13% #$)% *.% (%

87-3)17%*.,17+(&1%3*,0*.%(%)*.E'1%/1=*&1%)&711.:%

S)17)% 0(=1% ,01% (8*'*,9% ,-% =*13% -.'9% #$)% ,0(,%

71H5*71% &'())*+*&(,*-.2% +*',171/% 89% ),5/9:% #%

)1(7&0%1.E*.1%(''-3)%5)17)%,-%71/5&1%,01%+-&5)%

-+%/(,(%81*.E%/*)<'(91/%89%)1'1&,*.E%1*,017%,01%

;C!% -7% ,01% ,174% 71'1=(.,% ,-% ,01% #$% 81*.E%

&'())*+*1/:% C.&1% ,01% 5)17% 0()% /1,174*.1/% ,01%

&-771&,% &'())*+*&(,*-.2% )01% ,01.% )1'1&,)% ,01%

&-771&,%E7(/1:%"01%())-&*(,1/%&'())*+*&(,*-.%/(,(%

(./%#$%/(,(%+7-4%,01%),5/9%(71%(5,-4(,*&(''9%

<-<5'(,1/% *.,-% (% /(,(% ,(8'1:% L71=*-5)'9%

&'())*+*1/% #$)% &(.% 81% 71=*131/% (./% 1/*,1/%

3*,0*.%,01%)(41%*.,17+(&1:%T1,(%/(,(%(8-5,%,01%

),5/9% (71% ())*E.1/% (% 5.*H51% */1.,*+*&(,*-.%

.54817% ,0(,% *)% ())-&*(,1/% 3*,0% 1(&0% &'())*+*1/%

#$:% "0*)% (''-3)% &-4<(7*)-.% -+% #$)% 3*,0*.% (%

)*.E'1%,7*('%-7%(&7-))%,7*(')%301.%(<<7-<7*(,1:%

%

%

!"#$%&'()!"#$!%&'()*+!&,!-%)*)-'%!./0(1!('/'!/&!2$!

-%'..),)$(!)*/&!/#$!'33%)-'/)&*!('/'2'.$!/'2%$.4!

5*%1!('/'!6$%$7'*/!/&!-%'..),1)*+!/#$!89!'6$!%&'($(4!

%

% %

!"#$%&'*)!"#$!6$&6+'*):'/)&*!&,!;";89!('/'!)*/&!

6$%'/)&*'%!/'2%$.4!9'-#!<1./$=!56+'*!;%'..!-&*/')*.!

/#$!89!36$,$66$(!/$6=.!>)/#)*!/#$!-%'..!'*(!$'-#!

/$6=!#'.!.$7$6'%!3&..)2%$!?6'($.4!

%

%

(3)

! !

!"#$%&'()'!"#$!%&'($))!*+',!-.!/$+$(0123!4!)0567!426!4!

)123+$!89!*&':!0#$!)5;)$0!'*!89)!*1+0$&$6!;7!0#$!)0567!<=>!

?.!/$+$(0123!0#$!/@A!426!4!)123+$!%&$*$&&$6!0$&:!*1+0$&$6!

;7!0#$!/@A>!B.!/$+$(0123!4!3&46$!*&':!0#$!3&46$)!

4))'(140$6!,10#!0#$!%&$*$&&$6!0$&:C!"#$!6404!

*&':!0#$)$!0#&$$!)0$%)!4&$!:$&3$6!426!)0'&$6C!

"! #$%&'()*$%!

"#$%&%$'()!*+,+(*-.!,%/+,!(#$!$(/(!-+#/+*,!0%))!

',+!(!&(*%+/1!23!$(/(!42$+),!(#$!$(/(!,2'*-+,!

0.+#!-2))+-/%#5!-)%#%-()!*+,+(*-.!$(/(6!7+!.(&+!

-*+(/+$! (#! (88)%-(/%2#! /.(/! ,%48)%3%+,!

%482*/%#5!9:!$(/(!/.2'5.!/.+!',+!23!4(88%#5!

/(;)+,! $'*%#5! /.+! :<=! 8*2-+,,6! >1! ',%#5! (#!

+?%,/%#5!-)(,,%3%-(/%2#!,/(#$(*$!@A<A9:B!(#$!(!

,/(#$(*$!*+,')/,!/(;)+C!0+!-(#!,/(#$(*$%D+!/.+!

9:,! 3*24! 4')/%8)+! /*%(),! 2#-+! /.+1! (*+!

-)(,,%3%+$6!<.+!*+,')/%#5!$(/(!-(#!#20!32*4!/.+!

;(,%,!32*!$%,-',,%2#,!(;2'/!0.+/.+*!A<A9:!%,!

/.+! 42,/! (88*28*%(/+! -)(,,%3%-(/%2#! ,1,/+4C!

0.+/.+*! /.+! 4+/(! $(/(! -2))+-/+$! (*+! ,'33%-%+#/!

/2! -248(*+! 9:,! (-*2,,! /*%(),C! (#$! .20! /.%,!

-2')$!-2#/*%;'/+!/2!/.+!-*+(/%2#!23! (#!2#/2)251!

32*!9:,6!

<.+!-)(,,%31%#5!(#$!*+',+!23!($&+*,+!+&+#/!

$(/(!-(#!;+!(!,%5#%3%-(#/!-2#/*%;'/%2#!/2!8(/%+#/!

,(3+/1C!(#$!%,!-*%/%-()!/2!2*8.(#!$%,+(,+!-)%#%-()!

*+,+(*-.C! 8(*/%-')(*)1! 0%/.%#! 8+$%(/*%-!

828')(/%2#,6! E/(#$(*$%D+$! &2-(;')(*%+,! (#$!

-2#-+8/,! 23! 9:,! 4(1! ())20! %#&+,/%5(/2*,! /2!

*+',+! ,(3+/1! $(/(! 3*24! 8*+&%2',! -)%#%-()!

*+,+(*-.C!0.%-.!02')$!,%5#%3%-(#/)1!*+$'-+!/.+!

-2,/!(#$!)+#5/.!23!-)%#%-()!*+,+(*-.!/*%(),6!

+,-,.,%&,)!

F6 <.+! G(/%2#()! H+,+(*-.! 9-/C! I#%/+$! E/(/+,!

A2#5*+,,C!FJKL6!

M6 <.+! >+)42#/! H+82*/C! :/.%-()! N*%#-%8)+,! (#$!

O'%$+)%#+,!32*!/.+!8*2/+-/%2#!23!.'4(#!,';P+-/,!

23! *+,+(*-.C! Q+8(*/4+#/! 23! R+()/.C! :$'-(/%2#!

(#$!7+)3(*+C!FJKJ!

S6 <.+! "#&+,/%5(/2*T,82#,2*+$! "GQ! %#! -)%#%-()!

/*%(),C! R((U+#,2#! AC! V1+! A=C! E(/.+*! WHC!

<2',,(%#/! QXC! A2#/*2)! A)%#! <*%(),6! FJYK!

X'#ZY@MB[F\FTJ6!

L6 <.+!V22$!(#$!Q*'5!9$4%#%,/*(/%2#C!Q+8(*/4+#/!

23! R+()/.! (#$! R'4(#! E+*&%-+,C! I#%/+$! E/(/+,!

23!94+*%-(C!FJS\6!

]6 ^33%-+!23!R'4(#!H+,+(*-.!N*2/+-/%2#C!Q+8(*/4+#/!

23! R+()/.! (#$! R'4(#! E+*&%-+,C! I#%/+$! E/(/+,!

23!94+*%-(C!FJ__6!

_6 A2442#! <+*4%#2)251! A*%/+*%(! 32*! 9$&+*,+!

:&+#/,C! G(/%2#()! A(#-+*! "#,/%/'/+C! G(/%2#()!

"#,/%/'/+,!23!R+()/.C!I#%/+$!E/(/+,!23!94+*%-(C!

9'5',/!JC!M\\_6!

K6 "#,/%/'/%2#()!H+&%+0!>2(*$C!G(/%2#()!H+,+(*-.!

9-/! 23! FJKLC! IE9C! (*+! 52&+*#+$! ;1! <%/)+! L]!

AVH! @A2$+! 23! V+$+*()! H+5')(/%2#,B! N(*/! L_C!

G(/%2#()! "#,/%/'/+,! 23! R+()/.C! Q+8(*/4+#/! 23!

R+()/.! (#$! R'4(#! E+*&%-+,C! I#%/+$! E/(/+,! 23!

94+*%-(6!

Y6 Q(/(! (#$! E(3+/1! W2#%/2*%#5! >2(*$! @QEW>BC!

G"R! N2)%-1! V2*! Q(/(! (#$! E(3+/1! W2#%/2*%#5C!

G(/%2#()!"#,/%/'/+,!23!R+()/.C!I#%/+$!E/(/+,!23!

94+*%-(C!X'#+!F\C!FJJY6!

J6 E82#,2*C!<.+!+#/%/1!*+,82#,%;)+!32*!*+5%,/+*%#5!

/.+! ,/'$1! LV WKH ´UHVSRQVLEOH SDUW\µ!C! (,!

$+3%#+$! %#! MF! AVH! @A2$+! 23! V+$+*()!

H+5')(/%2#,BC! N(*/! MF! AVH! ]\6SC! G(/%2#()!

"#,/%/'/+,!23!R+()/.C!Q+8(*/4+#/!23!R+()/.!(#$!

R'4(#!E+*&%-+,C!I#%/+$!E/(/+,!23!94+*%-(6!

F\6!"#$%&'()*+,-.-.+/"012'3$4$5"36!N2,/5*+E`=!

O)2;()! Q+&+)284+#/! O*2'86! H+/*%+&+$! M\F\T

\JTM\6!

!

Références

Documents relatifs

Background: Current treatment options for stage III non-small cell lung cancer (NSCLC) consist of different combinations of chemotherapy, surgery, radiotherapy and

Keywords: Sentiment Analysis, Opinion Detection, Natural Language Pro- cessing, Machine Learning, Data Mining, Feature Selection, Text

In this paper, we introduce the basic framework of the OVAE and how OVAE is used to represent and analyze all adverse events reported in the product package inserts

A data science approach to drug safety: Semantic and visual mining of adverse drug events from clinical trials of pain treatments... A data science approach to

A data science approach to drug safety: Semantic and visual mining of adverse drug events from clinical trials of pain treatments... A data science approach to

We first con- struct a graph using candidate ADE extracted from biomedical literature, and then propose a method to select critical vertices from the graph as core vertices with

Key findings are: (1) Health care providers involved in adverse events need to be given the opportunity to talk about their experience; (2) The best way to provide support is

A robust method to explore the formation and interaction histories of nearby galaxies, where individual stars can be resolved (such as the Magellanic Clouds), entails the study of